Healthcare AI Beyond the Demonstration

Healthcare AI becomes consequential only when its output enters a real decision. Before that moment it is a demonstration: perhaps clever, useful, and scientifically interesting, but still protected from the disorder of care. Clinical systems contain missing histories, copied fields, delayed results, local codes, shifting populations, hurried staff, uneven follow-up, and incentives that do not line up neatly with patient welfare. A model trained on this record does not see the patient. It sees a representation produced by institutions.

That is why evaluation must begin before the final accuracy table. Teams need to ask what objective was chosen, which patients disappeared from the data, whether time was aligned honestly, how predictions are calibrated, and whether performance survives another site or period. They also need a shadow architecture around the model: evidence retrieval, access control, workflow design, human review, monitoring, incident response, auditability, and a safe way to stop. Prospective trials and staged deployment matter because an offline result cannot reveal every harm created by a live queue or interface.

The reading paths move from MYCIN’s explainable rules to modern embeddings, platform governance, causal inference, intimate chatbots, and insurance risk scoring. The aim is not to claim that healthcare is too difficult for artificial intelligence. It is to insist that difficulty lives in more places than the model. A system safe enough for healthcare must preserve meaning across data exchange, show its limits, fit the work, and leave a recoverable trail when reality disagrees with prediction.

Three browser laboratories let you test parts of that argument. The Human + AI ICU Prediction Laboratory uses wholly synthetic forecasts to separate ranking, calibration, shared errors and population shift. The Music of Missing Data changes which measurements disappear while keeping the synthetic population fixed. The Shape of Waiting follows both a queue’s distribution and the person its average can conceal. These are experiments in stated models, not patient-risk tools or evidence of clinical effectiveness.